Thought Leadership
Digital Health Tools and Patient Support in China
Discover how China is leading the way in revolutionizing healthcare through digital technologies. With a staggering $1.5 trillion investment plan and innovative solutions, China aims to bridge healthcare gaps, engage patients, and set the stage for the future of global healthcare...
3 Translation Methodologies for Life Sciences Documentation
This post outlines three translation methodologies for life sciences documentation, emphasizing their importance due to the complexity and specific needs of clinical documentation translation. It describes standard translation, back translation & reconciliation, and...
Patient Recruitment: A Critical Component Often Overlooked, Making it The Regrettable Spend
Patient recruitment (PR) is a layered, complex endeavor. It is not just placing social media advertisements, nor is it just emailing as many patients and sites as possible. It is a holistic, systematic process that can be the single biggest stumbling block of an entire study. ...
5 Ways to Increase Diversity in Medical Product Development
This blog emphasizes the critical need for more inclusive clinical trials, highlighting efforts by regulatory bodies like the FDA to ensure diverse patient representation in clinical research. It outlines the impact of variables like age, genetics, and geography on drug response,...
Be Where Your Patients Are: Effective Digital Strategies For Patient Recruitment
Did you know that 15–20% of studies do not launch due to unsuccessful patient enrollment? In the past, recruiting the RIGHT patient population has been complex, expensive, and challenging, especially when it comes to rare diseases or niche requirements. Join TPT Digital’s...
Enabling Diversity & Inclusion in Clinical Trials: A CRO & IRB Perspective
Diversity in clinical research is imperative to ensure the safety and effectiveness of drugs and medical devices for all people—and everyone in the industry is a key stakeholder. Clinical trials today still lack ethnic diversity, and to make trials more inclusive and improve...
How Life Sciences Companies Can Detect Adverse Events on Social Media
An overview of the evolving role of social media in pharmacovigilance (PV) for pharmaceutical companies, highlighting how social media platforms have become crucial sources for adverse event reporting and post-marketing safety information, and outlining the challenges and...